IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $2.44, $0.45 worse than the analyst estimate of $2.89. Revenue for the quarter came in at $1 billion versus the consensus estimate of $1.01 billion.

GUIDANCE:

IDEXX Labs sees FY2024 EPS of $10.31-$10.59, versus the consensus of $11.01. IDEXX Labs sees FY2024 revenue of $3.885-3.945 billion, versus the consensus of $3.937 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.